ELIECER
COTO GARCIA
Catedrático de Universidad
Hospital de Cabueñes
Gijón, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cabueñes (28)
2018
-
Role of syncope in predicting adverse outcomes in patients with suspected Brugada syndrome undergoing standardized flecainide testing
Europace, Vol. 20, Núm. FI1, pp. f64-f71
2016
-
Surveillance after cardiac arrest in patients with Brugada syndrome without an implantable defibrillator: An alarm effect of the previous syncope
International Journal of Cardiology, Vol. 218, pp. 69-74
2011
-
Amyloid precursor protein gene (APP) variation in late-onset alzheimer's disease
Journal of Molecular Neuroscience, Vol. 45, Núm. 1, pp. 5-9
-
Lack of association between protocadherin 11-X/Y (PCDH11X and PCDH11Y) polymorphisms and late onset Alzheimer's disease
Brain Research, Vol. 1383, pp. 252-256
-
Late-onset Alzheimer's disease is associated with mitochondrial DNA 7028C/haplogroup H and D310 poly-C tract heteroplasmy
Neurogenetics
-
Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: Evidence for an association to haplogroup H
Mitochondrion, Vol. 11, Núm. 1, pp. 176-181
2010
-
Bases clínicas y genéticas de la nefroesclerosis hipertensiva. Estudio NEFROSEN
Nefrologia, Vol. 30, Núm. 6, pp. 687-697
2008
-
The Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene promoter is not associated with late onset Alzheimer disease
Alzheimer Disease and Associated Disorders, Vol. 22, Núm. 2, pp. 177-180
2007
-
Myocyte enhancing factor-2A in Alzheimer's disease: Genetic analysis and association with MEF2A-polymorphisms
Neuroscience Letters, Vol. 411, Núm. 1, pp. 47-51
2006
-
The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction
Journal of Medical Genetics, Vol. 43, Núm. 2, pp. 167-169
2004
-
A single-nucleotide polymorphism in the human p27kip1 gene (-838C>A) affects basal promoter activity and the risk of myocardial infarction
BMC Biology, Vol. 2
-
Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease
Neuroscience Letters, Vol. 370, Núm. 2-3, pp. 151-154
2003
-
5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction
Clinical Science, Vol. 104, Núm. 3, pp. 241-245
-
Association between genetic variation in the Y chromosome and hypertension in myocardial infarction patients
American Journal of Medical Genetics, Vol. 122 A, Núm. 3, pp. 234-237
-
Detección directa de mutaciones malignas en pacientes con miocardiopatía hipertrófica
Revista Espanola de Cardiologia, Vol. 56, Núm. 10, pp. 1022-1025
-
Hypertrophic cardiomyopathy: Low frequency of mutations in the β-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients
Clinical Chemistry, Vol. 49, Núm. 8, pp. 1279-1285
-
IL-1α (-889) promoter polymorphism is a risk factor for osteomyelitis
American Journal of Medical Genetics, Vol. 119 A, Núm. 2, pp. 132-136
-
The T-786C endothelial nitric oxide synthase genotype and coronary artery disease [1] (multiple letters)
Journal of the American College of Cardiology
2002
-
Association between the TNFα-308 A/G polymorphism and the onset-age of Alzheimer disease
American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 114, Núm. 5, pp. 574-577
-
Variation in the lipoprotein receptor-related protein, α2-macroglobulin and lipoprotein receptor-associated protein genes in relation to plasma lipid levels and risk of early myocardial infarction
Coronary Artery Disease, Vol. 13, Núm. 5, pp. 251-254